Metraipolis › archive › dc_92a4cf79dc40

Reduced DPP9 levels sensitize experimental breast tumors to combinatory treatment with irradiation and Olaparib — Europe PMC PMID:42358531

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42358531
DOI
10.3389/fonc.2026.1845048
License (as archived)
solo-consultazione
Archived
2026-10-31T14:31:44.493Z
SHA-256 of the archived text
5db79e7b03d7e3a35987ea3efe75c83c4cd76f721b0cf053f51e4c191fcf46c0
Stable URL of this page
https://metraipolis.com/documento/dc_92a4cf79dc40

How to cite

Reduced DPP9 levels sensitize experimental breast tumors to combinatory treatment with irradiation and Olaparib — Europe PMC PMID:42358531 — Europe PMC (en), https://europepmc.org/article/MED/42358531 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_92a4cf79dc40 (Metraipolis archive dc_92a4cf79dc40, sha256 5db79e7b03d7e3a35987ea3efe75c83c4cd76f721b0cf053f51e4c191fcf46c0)
BibTeX
@misc{dc92a4cf79dc40,
  title = {Reduced DPP9 levels sensitize experimental breast tumors to combinatory treatment with irradiation and Olaparib — Europe PMC PMID:42358531},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42358531},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_92a4cf79dc40; sha256 5db79e7b03d7e3a35987ea3efe75c83c4cd76f721b0cf053f51e4c191fcf46c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42358531. Agents can read the archived copy with the MCP tool read_document.